Mineralocorticoid receptor antagonists for chronic central serous chorioretinopathy: systematic review and meta-analyses

BACKGROUND: Mineralocorticoid receptor antagonists (MRAs) are widely used for chronic central serous chorioretinopathy (cCSCR), but their effectiveness remains unclear. This research was conducted to evaluate the efficacy of this drugs for cCSCR. METHODS: This is a review of randomized clinical tria...

Descripción completa

Detalles Bibliográficos
Autores principales: Felipe, Camila Q., Biancardi, Ana Luiza, Civile, Vinicius T., Carvas Junior, Nelson, Serracarbassa, Pedro D., Koike, Marcia K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9172176/
https://www.ncbi.nlm.nih.gov/pubmed/35672807
http://dx.doi.org/10.1186/s40942-022-00385-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9172176/
https://www.ncbi.nlm.nih.gov/pubmed/35672807
http://dx.doi.org/10.1186/s40942-022-00385-1

Ejemplares similares